ArticleJournal of ovarian research2021

Pretreatment with LCK inhibitors chemosensitizes cisplatin-resistant endometrioid ovarian tumors.

Katie K Crean-Tate et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.